Aptus Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE15XJ01010
  • NSEID:
  • BSEID: 544529
INR
246.70
-5 (-1.99%)
BSENSE

Feb 06

BSE+NSE Vol: 20000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024

Compare Balance Sheet Results of Aptus Pharma
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
28.45
-23.45
-82.43%
Share Warrants & Outstandings
Total Reserve
1.97
107.51
-105.54
-98.17%
Shareholder's Funds
6.97
138.48
-131.51
-94.97%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.62
1.99
0.63
31.66%
Secured Loans
1.51
1.99
-0.48
-24.12%
Unsecured Loans
1.11
0.00
1.11
0.00%
Deferred Tax Assets / Liabilities
-0.07
0.92
-0.99
-107.61%
Other Long Term Liabilities
0.25
0.00
0.25
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.80
2.91
-0.11
-3.78%
Current Liabilities
Trade Payables
1.31
102.54
-101.23
-98.72%
Other Current Liabilities
3.04
11.07
-8.03
-72.54%
Short Term Borrowings
7.74
32.87
-25.13
-76.45%
Short Term Provisions
0.00
2.73
-2.73
-100.00%
Total Current Liabilities
12.08
149.21
-137.13
-91.90%
Total Liabilities
21.85
290.59
-268.74
-92.48%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.86
39.10
-37.24
-95.24%
Less: Accumulated Depreciation
0.87
22.88
-22.01
-96.20%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.99
16.22
-15.23
-93.90%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
2.12
-2.12
-100.00%
Long Term Loans & Advances
0.00
6.64
-6.64
-100.00%
Other Non Current Assets
1.12
0.01
1.11
11,100.00%
Total Non-Current Assets
2.11
24.98
-22.87
-91.55%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.06
45.48
-38.42
-84.48%
Sundry Debtors
5.64
133.46
-127.82
-95.77%
Cash and Bank
5.21
1.47
3.74
254.42%
Other Current Assets
0.00
0.78
-0.78
-100.00%
Short Term Loans and Advances
1.82
84.41
-82.59
-97.84%
Total Current Assets
19.74
265.61
-245.87
-92.57%
Net Current Assets (Including Current Investments)
7.65
116.40
-108.75
-93.43%
Total Current Assets Excluding Current Investments
19.74
265.61
-245.87
-92.57%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
21.85
290.59
-268.74
-92.48%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
10.36
34.86
-24.50
-70.28%
Book Value per share (adjusted)
13.93
46.90
-32.97
-70.30%
Annual - Borrowings
Borrowings 10.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.25 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024

Annual - Fixed Assets
Fixed Assets 0.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 19.74 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024